A carregar...

Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia

Objective: The current study examined the efficacy and safety of rasagiline, a selective MAO-B inhibitor, for the treatment of persistent negative symptoms. Methods: Sixty people with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, schizophrenia or schizoaffective disorder, wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Schizophr Bull
Main Authors: Buchanan, Robert W., Weiner, Elaine, Kelly, Deanna L., Gold, James M., Keller, William R., Waltz, James A., McMahon, Robert P., Gorelick, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4466175/
https://ncbi.nlm.nih.gov/pubmed/25368372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbu151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!